Related Experiment Video
Updated: May 11, 2026

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
Updates in breathomics behavior in ischemic heart disease and heart failure, mass-spectrometry
Basheer Abdualah Marzoog1, Peter Chomakhidze2, Daria Gognieva2
1Department of Cardiology, Sechenov University, Moscow 119991, Moskva, Russia. marzug@mail.ru.
Insights
Exhaled breath analysis shows potential for diagnosing heart failure and ischemic heart disease (IHD). Further research is needed to understand volatile organic compounds (VOCs) as biomarkers for these conditions.
Area of Science:
- Cardiology
- Biomarker Discovery
- Analytical Chemistry
Background:
- Cardiovascular diseases (CVD), particularly ischemic heart disease (IHD) and heart failure, are leading global causes of disability and mortality.
- Current diagnostic and management strategies for IHD and heart failure are insufficient, highlighting the need for improved early detection methods.
- The role of early risk factor detection through modern strategies in CVD is underestimated and requires further investigation.
Purpose of the Study:
- To review and interpret existing literature on volatile organic compounds (VOCs) in exhaled breath.
- To analyze various methods used for breath analysis in patients diagnosed with IHD and heart failure.
Main Methods:
- Systematic literature searches were conducted using Scopus and PubMed databases.
- Keywords focused on breath analysis, IHD, and heart failure.
- A total of 20 relevant studies were identified and included in the review. The study is registered in PROSPERO (CRD42023470556).
Main Results:
- The current body of research on VOCs in IHD and heart failure is limited, necessitating further investigation for comprehensive understanding.
- Existing studies indicate that metabolic alterations in the heart can be reflected in exhaled breath.
- The scarcity of published articles poses significant challenges for data interpretation.
Conclusions:
- Exhaled breath analysis presents a promising avenue as a novel biomarker for the diagnosis and prevention of heart failure and IHD.
- Analysis of exhaled breath can serve as a non-invasive indicator, mirroring the metabolic changes associated with heart failure and IHD.
Background:
Cardiovascular disease (CVD) and associated sequalae remain the leading cause of disability worldwide. Ischemic heart disease (IHD) and heart failure are the most common etiologies of morbidity and mortality worldwide. This is due to the poor diagnostic and management methods for heart failure and IHD. Early detection of related risk factors through modern strategies is underestimated and requires further research.
Aim:
To interpret data from the published literature on volatile organic compounds (VOC), including all the methods used to analyze exhaled breath in patients with IHD and heart failure.
Methods:
Searches for specific keywords were performed on Scopus and PubMed. A total of 20 studies were identified in breath analysis and IHD and heart failure. The study is registered in PROSPERO (Registration No. CRD42023470556).
Results:
Considering the articles found, more research is required to gain a full understanding of the role of VOCs in IHD and heart failure. However, the existing literature demonstrates that cardiac metabolic changes can be expressed in exhaled air. The number of papers found is extremely low, making interpretation extremely difficult.
Conclusion:
Exhaled breath analysis can be a novel biomarker for the diagnosis and prevention of heart failure and IHD. Exhaled breath analysis can be used as a mirror to reflect the metabolic changes related to IHD and heart failure.
More Related Videos
11:02Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
09:43Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging
Published on: January 10, 2025